Susquehanna International Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Susquehanna International Group’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,700	Closed	-$87K	–	14589
2022 Q1	$87K	Sell	52,700 -12,300	-19%	-$21.9K	﹤0.01%	12008
2021 Q4	$155K	Buy	65,000 +32,100	+98%	+$131K	﹤0.01%	11758
2021 Q3	$180K	Buy	+32,900	New	+$204K	﹤0.01%	11612
2021 Q2	–	Sell	-14,300	Closed	-$116K	–	13580
2021 Q1	$116K	Buy	+14,300	New	+$156K	﹤0.01%	11784

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Susquehanna International Group's KLDO Position: Q1 2022 in Review

Susquehanna International Group sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2022, closing a stake of 45,490 shares — an estimated $81.2K sold.

Susquehanna International Group first reported a position in KLDO in Q1 2021 and held it in 3 quarters. The position peaked at $303K in Q1 2021. 63 funds tracked by Wall St. Rank hold KLDO as of Q1 2022.

Susquehanna International Group reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Susquehanna International Group sold 45,490 Kaleido Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $81.2K.
Susquehanna International Group first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Susquehanna International Group's Kaleido Biosciences, Inc. Common Stock position peaked at $303K in Q1 2021.
63 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.